alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 10.36



COMPENSATION POLICY FOR DIRECTORS OF ORCHID BIOSCIENCES, INC.



EFFECTIVE JANUARY 1, 2004



Compensation Policy



|                                                                                              |  |   |       
|--------------------------------------------------------------------------------------------- |  | - | ------
|Board of Directors:                                                                           |  |   |       
|                                                                                              | 
|Annual retainer-chairman                                                                      |  | $ | 15,000
|Annual retainer-director                                                                      |  | $ | 12,500
|Meeting attendance fee                                                                        |  | $ | 3,000 
|Telephonic meetings will be paid at the prorated level of $500 per hour.                      |  |   |       
|                                                                                              | 
|Audit Committee:                                                                              |  |   |       
|                                                                                              | 
|Annual retainer-chairperson                                                                   |  | $ | 5,000 
|Annual retainer-committee members                                                             |  | $ | 1,500 
|Meeting attendance fee:                                                                       |  | $ | 1,000 
|Meeting attendance fee (in person for meetings held on days separate from full Board meeting) |  | $ | 3,000 
|Telephonic meetings will be paid at the prorated level of $500 per hour.                      |  |   |       
|                                                                                              | 
|Compensation Committee                                                                        |  |   |       
|                                                                                              | 
|No annual retainer to be paid to compensation committee chairperson or members.               |  |   |       
|Meeting attendance fee                                                                        |  | $ | 1,000 
|Meeting attendance fee (in person meetings held on days separate from full Board meeting)     |  | $ | 3,000 
|Telephonic meetings will be paid at the prorated level of $500 per hour.                      |  |   |       



Board members and committee members
receive stock option grants both upon joining the Board and on an annual basis in line with recommendations by the Compensation Committee, which grants are non-qualified stock options under our 2000 Employee, Director and Consultant Stock Incentive
Plan, which grants typically vest in monthly increments over 4 years.
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<RESTATED> 
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          JUN-30-1997
<PERIOD-START>                             JUL-01-1996
<PERIOD-END>                               DEC-31-1996
<CASH>                                       1,355,780
<SECURITIES>                                         0
<RECEIVABLES>                                6,324,366
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             2,574,171
<PP&E>                                      22,525,155
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                              32,779,472
<CURRENT-LIABILITIES>                       12,680,484
<BONDS>                                      8,713,273
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                  11,385,715
<TOTAL-LIABILITY-AND-EQUITY>                32,779,472
<SALES>                                     17,982,758
<TOTAL-REVENUES>                            17,982,758
<CGS>                                       15,005,541
<TOTAL-COSTS>                               15,005,541
<OTHER-EXPENSES>                             2,896,281
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             698,127
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            564,358
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (52,833)
<EPS-PRIMARY>                                   (0.01)
<EPS-DILUTED>                                        0
        

</TABLE>
**Exhibit32.2**

 

**Certificationof Executive Vice President and Chief Financial Officer**

**Pursuantto Section 906 of the Sarbanes-Oxley Act of 2002**

 

The undersigned officer ofWatson Pharmaceuticals, Inc. (the “Company”), hereby certifies, to suchofficer’s knowledge, that:

 

(i)            the accompanying Quarterly Report onForm 10-Q of the Company for the quarter ended June 30, 2004 (the “Report”)fully complies with the requirements of Section 13(a) or Section 15(d), asapplicable, of the Securities Exchange Act of 1934, as amended; and

 

(ii)           theinformation contained in the Report fairly presents, in all material respects,the financial condition and results of operations of the Company.

 

 
| Date:  August 6, 2004 |
|----------------------------|
|                       |
|                       | By: | **/s/ Charles P. Slacik** |
|                       |   |   |
|                       |   | Charles P. Slacik |
|                       | ** ** | Executive Vice President – Chief Financial Officer |
|                       | ** ** | (Principal Financial Officer) |

 

 

The foregoing certification is beingfurnished solely to accompany the Report pursuant to 18 U.S.C. § 1350, and isnot being filed for purposes of Section 18 of the Securities Exchange Act of1934, as amended, and is not to be incorporated by reference into any filing ofthe Company, whether made before or after the date hereof, regardless of anygeneral incorporation language in such filing.

 

----
NOT FOR PUBLICATION

UNITED STATES COURT OF APPEALS

FOR THE NINTH CIRCUIT

GABRIEL MINASYAN; HASMIK

MINASSIAN ; HAKOB MINASYAN

,

Petitioners,

v.

MERRICK B. GARLAND, Attorney General,

Respondent. No. 15

- 70862

Agency Nos. A075

- 648

- 887

A075

- 648

- 888

A075

- 648

- 890

MEMORANDUM *

On Petition for Review of an Order of the Board of Immigration Appeals

Submitted May 17, 2022 * *

Before: CANBY, TASHIMA, and NGUYEN, Circuit Judges.

Gabriel, Hasmik, and Hakob Minasyan , native s and citizen s of Armenia

,

petition for review of the Board of Immigration Appeals’ (“BIA”) order of

February 1 9 , 2015, denying their motion to reopen. We have jurisdiction under 8

* This disposition is not appropriate for publication and is not precedent except as provided by Ninth Circuit Rule 36

- 3.

** The panel unanimously concludes this case is suitable for decision without oral argument. See Fed. R. App. P. 34(a)(2). 

# FILED

MAY 20 2022

MOLLY C. DWYER, CLERK

U.S. COURT OF APPEALS2 15

- 70862

U.S.C. § 1252. We review for abuse of discretion th e denial of a motion to reopen.

Cano

- Merida v. INS , 311 F.3d 960, 964 (9th Cir. 2002). We deny the petition for

review.

T he BIA did not abuse its discretion in denying the motion

, which was not

supported as required by the governing regulation

. See 8 C.F.R. § 1003.2(c)(1)

(“A motion to r e open .

. . shall be supported by affidavits or other evidentiary

material.” ) ; see also INS v. Wang , 450 U.S. 139, 143 (1981) ( enforcing a prior

regulation that requir ed motion s to reopen to be supported by affidavit s or other

evidentiary material ). Petitioners offer no support for their contention that the BIA

should have excused them from this requirement because they filed their motion to

reopen pro se

.

The record does not support Pe titioners’ contention that the BI A abused its

discretion by failing to “consider the most recent relevant country condition profile

published by the United States State Department” under Abassi v. INS , 305 F.3d

1028, 1029 (9th Cir. 2002) , because they filed their motion pro se

. That case is

inapplicable for several reasons, including that Petitioners failed to identify

materially changed circumstances that any such profile would demonstrate

.

T he temporary stay of removal remains in place until issuance of the

mandate.

PETITION FOR REVIEW DENIED

.
EXHIBIT 32.1

                          CERTIFICATION PURSUANT TO
                           18 U.S.C. SECTION 1350
                           AS ADOPTED PURSUANT TO
                SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly Report of First Federal Bancorp, Inc. (the
"Company"), on Form 10-QSB for the period ended June 30, 2004, dated the
date of this Certification (the "Report"), I, J. William Plummer, the
President and the Chief Executive Officer of the Company, certify, pursuant
to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:

      1.    The Report complies with the requirements of section 13(a) or
      15(d) of the Securities Exchange Act of 1934; and

      2.    The information contained in the Report fairly presents, in all
      material respects, the financial condition and results of operations
      of the Company.


Date: August 12, 2004                  By: /s/ J. William Plummer
                                           -----------------------------
                                           J. William Plummer
                                           President and Chief Executive
                                           Officer


A signed original of this written statement required by Section 906 has
been provided to First Federal Bancorp, Inc., and will be retained by First
Federal Bancorp, Inc., and furnished to the Securities and Exchange
Commission or its staff upon request.


<PAGE>
Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with this Quarterly Report on Form 10-Q of Susser Holdings Corporation (the Company) for the three months ended April 1,
2007 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Mary E. Sullivan, Executive Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted
pursuant to § 906 of the Sarbanes-Oxley Act of 2002 that:



| | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
| | --- | ---------------------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|                   |  |  |  |                             |  |                                                      |  |                     
|------------------ |  |  |  | --------------------------- |  | ---------------------------------------------------- |  | --------------------
|Date: May 16, 2007 |  |  |  | SUSSER HOLDINGS CORPORATION
|                   |  |  |  |                            
|                   |  |  |  |                             |  | By                                                   |  | /s/ Mary E. Sullivan
|                   |  |  |  |                             |  | Mary E. Sullivan                                    
|                   |  |  |  |                             |  | Executive Vice President and Chief Financial Officer

This certification accompanies this Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of
2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.
|   | 1. | The      Company’s Annual Report on Form 10-K for the year ended December 31, 2009      (the “Form 10-K”) fully complies with the requirements of Section 13(a) or      15(d) of the Securities Exchange Act of 1934, as amended;    and |
|--------|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 2. | Information      contained in the Form 10-K fairly presents, in all material respects, the      financial condition and results of operations of the    Company. |
|--------|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | Dated:      March 4, 2010 | By:                                        | /s/      DAVID T. TABER      |   |
|--------|---------------------------|--------------------------------------------|------------------------------|--------|
|   |                      | David      T. Taber                        |                         |
|   |                      | President      and Chief Executive Officer |                         |
|   | Dated:      March 4, 2010 |                                       |                         |   |
|   |                      | By:                                        | /s/      MITCHELL A. DERENZO |   |
|   |                      | Mitchell      A. Derenzo                   |                         |
|   |                      | Executive      Vice President and          |                         |
|   |                      | Chief      Financial Officer               |                         |

----
cphi10kex103123112.htm


Exhibit 10.3


 












Re: Service about being independent director, member of the Audit Committee, and member of the Nominating and Compensation Committee of China Pharma Holdings, Inc.


 


December 24, 2012







Dear Mr. Baowen Dong,







On behalf of the Board of Directors and the Company, I am pleased to welcome you to join the Board of the China Pharma Holdings, Inc. as an independent director, member of the Audit Committee, and member of the Nominating and Compensation Committee. I look forward to working with you. Your starting date will be the date of the board approves your engagement and your engagement for this term will end on the date of the next annual shareholders meeting.







Your compensation will consist of the following:



	
1)  

	
A retainer of RMB 40,000 per year, payable quarterly within 5 days of the end of the quarter;












If you agree to the terms and conditions stated above, please sign and date this letter below.







I look forward to working with you and sincerely hope that your service will be enjoyable and rewarding.







Sincerely












Chairman of the Board


China Pharma Holdings, Inc












Response:


This letter correctly sets forth the understanding of Mr. Baowen Dong.












By:     /s/ Baowen Dong







Date:
Order entered December 18, 2014

In The

Court of Appeals 

Fifth District of Texas at Dallas 

No. 05-14-00133-CV

GREGORY B. BATEN TRUST, INTERVENOR, Appellant

V.

BRANCH BANKING AND TRUST COMPANY AND RICHARD W. HEATH, Appellees

On Appeal from the 95th Judicial District Court

Dallas County, Texas

Trial Court Cause No. DC-13-08390

ORDER

We DENY appellee Richard W. Heath’s December 17, 2014 request for additional time 

for oral argument at submission, currently scheduled for January 6, 2015 at 11:00 am. 

/s/ DAVID EVANS 

PRESIDING JUSTICE
```

[Congressional Bills 108th Congress]
[From the U.S. Government Publishing Office]
[H.R. 564 Introduced in House (IH)]

108th CONGRESS
  1st Session
                                H. R. 564

    To suspend temporarily the duty on polymer masking material for 
                     aluminum capacitors (UPICOAT).

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            February 5, 2003

  Mr. DeMint introduced the following bill; which was referred to the 
                      Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
    To suspend temporarily the duty on polymer masking material for 
                     aluminum capacitors (UPICOAT).

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. POLYMER MASKING MATERIAL FOR ALUMINUM CAPACITORS (UPICOAT).

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:
      

``    9902.34.41    Polymer masking   Free              No change         No change         On or before 12/
                     material for                                                            31/2005          ''
                     aluminum                                                                                  .
                     capacitors
                     (UPICOAT of 40%
                     solute
                     denatured
                     polymide and
                     60% solvent
                     diethyleneglyco
                     l
                     dimethylethers
                     (CAS No. 111-96-
                     6)) (provided
                     for in
                     subheading
                     2909.41.00)....

    (b) Effective Date.--The amendment made by subsection (a) applies 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of the enactment 
of this Act.
                                 <all>
```
# part-time by grouped work level
137574.00601/102040006v.1

BLANK ROME LLP

A Pennsylvania LLP

Jonathan M. Korn, Esquire

301 Carnegie Center, 3rd Floor

Princeton, NJ 08540

(609) 750-7700 (Phone)

(609) 750-7701 (Fax)

Korn@BlankRome.com

James N. Benedict (Pro Hac Vice)

Sean M. Murphy (Pro Hac Vice)

Robert C. Hora (Pro Hac Vice)

MILBANK, TWEED, HADLEY & MCCLOY LLP

1 Chase Manhattan Plaza

New York, NY 10005

(212) 530-5000 (Phone)

(212) 530-5219 (Fax)

Attorneys for Defendants

UNITED STATES DISTRICT COURT

DISTRICT OF NEW JERSEY

MARY ANN SIVOLELLA, for the use and benefit of the 

EQ/Common Stock Index Portfolio, the EQ/Equity Growth 

PLUS Portfolio, the EQ/Equity 500 Index Portfolio, the 

EQ/Large Cap Value PLUS Portfolio, the EQ/Global MultiSector Equity Portfolio, the EQ/Mid Cap Value PLUS 

Portfolio, the EQ/GAMCO Small Company Value, and the 

EQ/Intermediate Government Bond Index Portfolio,

Plaintiff,

vs.

AXA EQUITABLE LIFE INSURANCE COMPANY and 

AXA EQUITABLE FUNDS MANAGEMENT GROUP, 

LLC,

Defendants.

Civil Action No. 3:11-cv-04194 (PGS)(DEA)

and

Civil Action No. 3:13-cv-00312 (PGS)

Filed Electronically

GLENN D. SANFORD, et al.,

Plaintiffs,

vs.

AXA EQUITABLE FUNDS MANAGEMENT GROUP, 

LLC,

Defendant.

NOTICE OF WITHDRAWAL OF 

APPEARANCE OF PRO HAC VICE

COUNSEL IAN E. BROWNING

Case 3:11-cv-04194-PGS-DEA Document 242 Filed 03/04/16 Page 1 of 2 PageID: 14834
137574.00601/102040006v.1 -2-

Please take notice that Ian E. Browning, Esquire is no longer associated with Milbank Tweed 

Hadley & McCloy, LLP, and is no longer counsel of record representing Defendants AXA Equitable Life 

Insurance Company and AXA Equitable Funds Management Group, LLC in this matter. Accordingly,

kindly withdraw his individual appearance in the above-captioned action. 

All other attorneys appearing in the case from Milbank Tweed Hadley & McCloy, LLP, and 

Blank Rome LLP continue to represent Defendants AXA Equitable Life Insurance Company and AXA 

Equitable Funds Management Group, LLC and remain counsel of record.

Respectfully submitted,

/s/ Jonathan M. Korn

JONATHAN M. KORN

BLANK ROME LLP

A Pennsylvania LLP

301 Carnegie Center, 3rd Floor

Princeton, NJ 08540

Attorneys for Defendants

Dated: March 4, 2016

Case 3:11-cv-04194-PGS-DEA Document 242 Filed 03/04/16 Page 2 of 2 PageID: 14835
Exhibit 32.2

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

Solely for the purposes of complying with 18 U.S.C. Section 1350, as adopted pursuantto Section 906 of the Sarbanes-Oxley Act of 2002, I, the undersigned Chief FinancialOfficer of Speaking Roses International, Inc., a Utah corporation (the"Company"), hereby certify, based on my knowledge, that the Quarterly Report onForm 10-KSB of the Company for the three months ended March 31, 2004 (the"Report") fully complies with the requirements of Section 13(a) of theSecurities Exchange Act of 1934 and that information contained in the Report fairlypresents, in all material respects, the financial condition and results of operations ofthe Company.

|                                                       | /s/ Reed E. Pew |
|-------------------------------------------------------|-----------------|
| Reed E. Pew,     Chief Financial Officer
May 21, 2004 |
DISTRICT COURT OF APPEAL OF THE STATE OF FLORIDA

FOURTH DISTRICT

FREDERICK JOHNSON,

Appellant,

v.

STATE OF FLORIDA,

Appellee.

No. 4D2023-2790

[February 8, 2024]

Appeal of order denying rule 3.800 motion from the Circuit Court for 

the Seventeenth Judicial Circuit, Broward County; Hon. Thomas Coleman, 

Judge; L.T. Case No. 88-24663CF10A. 

Frederick Johnson, South Bay, pro se.

No appearance required for appellee.

PER CURIAM.

Affirmed.

KLINGENSMITH, C.J., GROSS and FORST, JJ., concur.

* * *

Not final until disposition of timely filed motion for rehearing.